1. Immunology/Inflammation
  2. NO Synthase
  3. Carboxy-PTIO potassium

Carboxy-PTIO potassium 

目录号: HY-18734A
产品使用指南

Carboxy-PTIO potassium 是一种有效的一氧化氮 (NO) 清除剂,能与 NO 快速反应产生 NO2。Carboxy-PTIO potassium 通过对脂多糖诱导大鼠模型中 NO 的直接清除作用,可预防低血压和内毒素休克。

MCE 的所有产品仅用作科学研究,我们不为任何个人用途提供产品和服务

Carboxy-PTIO potassium Chemical Structure

Carboxy-PTIO potassium Chemical Structure

CAS No. : 148819-94-7

1.  客户无需承担相应的运输费用。

2.  同一机构(单位)同一产品试用装仅限申领一次,同一机构(单位)一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户

Size Stock
100 mg   Get quote  
250 mg   Get quote  
500 mg   Get quote  

* Please select Quantity before adding items.

Customer Review

Top Publications Citing Use of Products
  • 生物活性

  • 纯度 & 产品资料

  • 参考文献

Description

Carboxy-PTIO potassium is a potent nitric oxide (NO) scavenger that can make a quick reaction with NO to produce NO2. Carboxy-PTIO potassium can prevent hypotension and endotoxic shock through the direct scavenging action against NO in lipopolysaccharide-stimulated rat model[1][2][3].

In Vitro

Carboxy-PTIO potassium (200 μM; 1 h prior to physalin A; 24 hours) significantly suppresses the stimulation of NO expression induced by physalin A treatment, but no change is observed in Carboxy-PTIO treatment alone[1].
Carboxy-PTIO potassium (200 μM; 1 h prior to physalin A; 24 hours) reduces physalin A-induced cleavage of procaspase-3 and PARP, down-regulated ICAD expression,diminishing DNA fragmentation in nuclei[1].
Carboxy-PTIO potassium (200 μM; 1 h prior to physalin A; 24 hours) shows no effect on iNOS expression. However, decreased-mTOR and p-mTOR levels induced by physalin A is reversed by Carboxy-PTIO with concomitant suppression of LC3 I to LC3 II conversions in A375-S2 cells [1].

Western Blot Analysis[1]

Cell Line: A375-S2 cells
Concentration: 200 μM
Incubation Time: 1 h prior to physalin A; 24 hours
Result: Diminished physalin A-induced procaspase-3 and PARP cleavage.
In Vivo

Carboxy-PTIO (intravenous injection; 0.056-1.70 mg/kg/min; infused for 1 hr beginning 90 min after the LPS injection 90 min) treatment improves the hypotension, renal dysfunction and survival rate in Lps-treated rats. But it does not affect each parameter in naomal rats[3].

Animal Model: SD rats[3]
Dosage: 0.056-1.70 mg/kg/min
Administration: Intravenous injection; 0.056-1.70 mg/kg/min; infused for 1 hr beginning 90 min after the LPS injection 90 min
Result: Exhibited a potent therapeutic value in endotoxin shock through the direct scavenging action against NO.
Molecular Weight

315.39

Formula

C₁₄H₁₆KN₂O₄

CAS No.

148819-94-7

SMILES

[O]N1C(C)(C)C(C)(C)[N+]([O-])=C1C2=CC=C(C(O[K])=O)C=C2

Shipping

Room temperature in continental US; may vary elsewhere.

Storage

Please store the product under the recommended conditions in the Certificate of Analysis.

References
  • 摩尔计算器

  • 稀释计算器

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass   Concentration   Volume   Molecular Weight *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
× = ×
C1   V1   C2   V2

Keywords:

Carboxy-PTIONO SynthaseNitric oxide synthasesNOSNO synthaseNO scavengehypotensionendotoxic shockiNOSrenal dysfunctionInhibitorinhibitorinhibit

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称:

 

* 需求量:

* 客户姓名:

 

* Email:

* 电话:

 

* 公司或机构名称:

   留言给我们:

Bulk Inquiry

Inquiry Information

产品名称:
Carboxy-PTIO potassium
目录号:
HY-18734A
需求量: